David C Bupp - Net Worth and Insider Trading

David C Bupp Net Worth

The estimated net worth of David C Bupp is at least $5,916 dollars as of 2024-05-06. David C Bupp is the Director of Navidea Biopharmaceuticals Inc and owns about 154,657 shares of Navidea Biopharmaceuticals Inc (NAVB) stock worth over $5,916. Details can be seen in David C Bupp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David C Bupp has not made any transactions after 2011-12-19 and currently still holds the listed stock(s).

Transaction Summary of David C Bupp

To

David C Bupp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David C Bupp owns 1 companies in total, including Navidea Biopharmaceuticals Inc (NAVB) .

Click here to see the complete history of David C Bupp’s form 4 insider trades.

Insider Ownership Summary of David C Bupp

Ticker Comapny Transaction Date Type of Owner
NAVB Navidea Biopharmaceuticals Inc 2011-12-19 director & CEO and President

David C Bupp Latest Holdings Summary

David C Bupp currently owns a total of 1 stock. David C Bupp owns 154,657 shares of Navidea Biopharmaceuticals Inc (NAVB) as of December 19, 2011, with a value of $5,916.

Latest Holdings of David C Bupp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NAVB Navidea Biopharmaceuticals Inc 2011-12-19 154,657 0.04 5,916

Holding Weightings of David C Bupp


David C Bupp Form 4 Trading Tracker

According to the SEC Form 4 filings, David C Bupp has made a total of 0 transactions in Navidea Biopharmaceuticals Inc (NAVB) over the past 5 years. The most-recent trade in Navidea Biopharmaceuticals Inc is the sale of 2,500 shares on December 19, 2011, which brought David C Bupp around $123,000.

Insider Trading History of David C Bupp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David C Bupp Trading Performance

GuruFocus tracks the stock performance after each of David C Bupp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David C Bupp is 55.78%. GuruFocus also compares David C Bupp's trading performance to market benchmark return within the same time period. The performance of stocks bought by David C Bupp within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David C Bupp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David C Bupp

Average Return

Average return per transaction

Outperforming Transactions

2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.81
Relative Return to S&P 500(%) 0.76

David C Bupp Ownership Network

Ownership Network List of David C Bupp

No Data

Ownership Network Relation of David C Bupp


David C Bupp Owned Company Details

What does Navidea Biopharmaceuticals Inc do?

Who are the key executives at Navidea Biopharmaceuticals Inc?

David C Bupp is the director & CEO and President of Navidea Biopharmaceuticals Inc. Other key executives at Navidea Biopharmaceuticals Inc include Chief Financial Officer Craig Dais , director & 10 percent owner Scott John K Jr. , and Chief Regulatory Officer Michel Mikhail .

Navidea Biopharmaceuticals Inc (NAVB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Navidea Biopharmaceuticals Inc (NAVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Navidea Biopharmaceuticals Inc (NAVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Navidea Biopharmaceuticals Inc (NAVB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Navidea Biopharmaceuticals Inc Insider Transactions

No Available Data

David C Bupp Mailing Address

Above is the net worth, insider trading, and ownership report for David C Bupp. You might contact David C Bupp via mailing address: 425 Metro Place North, Ste 400, Dublin Oh 43017.

Discussions on David C Bupp

No discussions yet.